Find Academic Supervisors

Allison PackView profile

Adjunct Assistant Professor

• Global Health
• HIV Prevention
• Sexual and Reproductive Health
• +3 more

Allison Pack, PhD, is an adjunct instructor in the Department of Health Behavior at the University of North Carolina’s Gillings School of Global Public Health, where she also earned her PhD. Her research focuses on global health interventions related to HIV, sexual and reproductive health, and adolescent health, with a specialization in assessing acceptability of biomedical HIV prevention products. She has conducted fieldwork in Tanzania, India, and Kenya, examining stakeholder perspectives on clinical trial participation and healthcare provider preparedness for new treatments. Dr. Pack teaches HBEH 772: Planning, Implementing and Evaluating Health Behavior Interventions . Her work emphasizes improving patient-clinician communication through adherence feedback systems and graphical data displays. Key themes include real-time adherence monitoring, ethical considerations in adolescent clinical trials, and leveraging financial incentives to enhance HIV treatment outcomes. Her research has been published in Patient Education and Counseling , J Assoc Nurses AIDS Care , and AIDS Care , focusing on translational research bridging clinical and community settings. She collaborates with international organizations to develop culturally appropriate health communication tools and has contributed to global public health strategies for microbicide introduction and viral suppression programs.

David KatzView profile

Professor

• Biomedical Engineering
• HIV Prevention
• Drug Delivery Systems
• +5 more

David F. Katz , Ph.D. is the Nello L. Teer, Jr. Distinguished Professor of Biomedical Engineering and Professor of Obstetrics & Gynecology at Duke University's Edmund T. Pratt, Jr. School of Engineering . With over 40 years of research experience, he focuses on biomedical engineering applications in reproductive health , particularly for HIV prevention and contraception . Education: Ph.D. in Biomedical Engineering, University of California, Berkeley (1972) Research Interests: His work spans biophysics , drug transport modeling , and microbicide functionality through: Physico-chemical analysis of semi-solid delivery systems In vivo measurement of vaginal gel distributions Computational modeling of deployment mechanics Physical barrier mechanisms against pathogens Biophysical properties governing gel acceptability Scientific Contributions: Developed multicompartmental pharmacokinetic models for tenofovir delivery Invented optical instruments for real-time gel thickness measurement Advanced confocal Raman/OCT systems for tissue drug analysis Explored non-Newtonian fluid mechanics in microbicide deployment Awards: Recipient of the Klein Family Distinguished Teaching Award (2018) and Capers & Marion McDonald Award (2010) from Pratt School of Engineering, with Fellow status in the American Institute for Medical and Biological Engineering (1998). Advising: Mentors graduate students in Biomedical Engineering at Duke and collaborates with faculty across UC Berkeley , Northwestern University , University of North Carolina , and University of Pittsburgh .

Jason DufourView profile

Associate Professor

• Infectious Disease Research
• Virology
• Immunology
• +4 more

Jason Dufour, DVM, DACLAM, is an Associate Professor of Medicine and Assistant Director for Clinical and Research Medicine at the Tulane National Primate Research Center. He holds a BS and DVM from Louisiana State University. His research focuses on infectious diseases (including SIV and COVID-19), gluten-sensitive enteropathy, and gene therapy applications in non-human primate models. His work spans virology, immunology, and veterinary medicine, with significant contributions to vaccine development, viral pathogenesis, and translational medicine. Key research interests include: Simian immunodeficiency virus (SIV) pathogenesis COVID-19 vaccine adjuvants and efficacy Gluten-induced enteropathy in macaques Gene therapy for genetic disorders Alcohol's impact on immune responses Publications highlight advancements in viral transmission blocking (e.g., CCR5 inhibitors), vaccine efficacy, and understanding disease mechanisms in non-human primate models. His clinical work includes managing primate health and surgical interventions for conditions like degenerative joint disease and vascular complications. Dr. Dufour collaborates on NIH-funded studies and has pioneered translational research linking basic science to clinical applications. His expertise bridges veterinary medicine, immunology, and infectious disease research, making significant contributions to biomedical science.

Kyle Vincent CamardaView profile

Associate Professor

• Process Systems Engineering
• Product Design Optimization
• Chemical Process Design
• +4 more

Dr. Kyle Vincent Camarda is an Associate Professor in the Department of Chemical & Petroleum Engineering at The University of Kansas. He holds a BS in Chemical Engineering from the University of California, San Diego (1990), and MS (1994) and PhD (1997) degrees in Chemical Engineering from the University of Illinois at Urbana-Champaign. His research focuses on Process Systems Engineering , Product Design Optimization , and Chemical Process Design , with applications in sustainable separations, biomedical materials, and pharmaceutical formulations. Notable projects include developing water-compatible dental adhesives, optimizing microbicidal drug delivery systems, and designing lyophilized protein formulations using carbohydrate excipients. His publications span interdisciplinary topics such as photopolymerization dynamics for dental materials, mathematical modeling of biomedical fluid dynamics, and computational molecular design. Presentations include talks at AIChE Annual Meetings and international process systems engineering conferences. Dr. Camarda advises graduate students in chemical engineering and collaborates with colleagues in biomedical and materials science fields. His work has been featured in journals like Computers and Chemical Engineering , Chemical Engineering Science , and Journal of Biomechanics .

Monique FergusonView profile

Associate Professor

• HIV/AIDS Research
• Virus-Host Interactions
• Antiviral Drug Development
• +3 more

Monique Ferguson is an Associate Professor at the University of Texas Medical Branch (UTMB), where she serves as Director of the HIV Pathogenesis Laboratory and Co-Director of the Pathobiology and Host Defenses Course for first-year medical students. She holds dual roles as a researcher and educator, focusing on HIV/AIDS research and medical education. Her academic affiliations include membership in the Baylor-UT Houston Center for AIDS Research (CFAR) and the International AIDS Society. Education: B.A. from Texas A&M University (1991), Ph.D. in 1997 and Postdoctoral Training in 2001, both at UTMB. Research interests center on HIV pathogenesis, antiviral drug development, aptamer-based therapies, and co-culture systems to study HIV/HCV co-infection and vaginal microbiome alterations. Her work also extends to developing microbicide intra-vaginal rings. As an educator, she emphasizes STEM outreach and medical student mentorship. Recent publications highlight her contributions to HIV virology, co-infection mechanisms, and translational research in antiviral therapies. Collaborative efforts include interdisciplinary projects on liver disease and diabetes in Hispanic populations.

Barbra RichardsonView profile

Research Professor

• HIV/AIDS Research
• Infectious Diseases Methodology
• Clinical Trials
• +5 more

Dr. Barbra Richardson is a Research Professor in the Department of Biostatistics and an Adjunct Research Professor in the Department of Global Health at the University of Washington School of Public Health. She is also a Joint Member at the Fred Hutch Cancer Center and affiliated with Harborview Medical Center. Her work focuses on statistical methodologies for infectious disease research, particularly HIV/AIDS and microbicide studies. She has contributed to over 250 peer-reviewed articles and played key roles in designing clinical trials and cohort studies globally. Education: PhD and MS in Biostatistics (UCLA), BA in Mathematics (Pomona College) Affiliations: Center for AIDS Research (CFAR), Kenya Research and Training Center (KRTC) Her research spans statistical analysis of infectious disease data, survival analysis with uncertain outcomes, and methods for handling missing data. She has advised international bodies like the WHO and served on national review committees. Notable contributions include developing breastmilk infectivity estimation methods and HIV prevention trial designs. Dr. Richardson has been recognized with the IAS Young Investigator Award and actively participates in global health initiatives such as the dapivirine ring research and Washington state's COVID-19 modeling efforts.

Rochelle K RosenView profile

Associate Professor

• Medical Anthropology
• Qualitative Research Methods
• Behavioral Health Interventions
• +5 more

Rochelle K. Rosen is an Associate Professor in the Departments of Psychiatry and Human Behavior, and Behavioral and Social Sciences at Brown University. She holds affiliations with the School of Public Health and Alpert Medical School. Her work focuses on qualitative research methods to design culturally relevant interventions, particularly in behavioral and preventive medicine. Dr. Rosen specializes in global health issues, including HIV prevention in the South Pacific (American Samoa), mobile health (mHealth) interventions, and substance use research. She has extensive experience in translational research, bridging qualitative insights with clinical applications. Her educational background includes a PhD from Brown University. Key research areas include using digital health technologies (e.g., text messaging, ingestible sensors) to improve adherence to medical regimens, particularly among marginalized populations such as incarcerated women and substance users. She has collaborated on NIH-funded projects addressing obesity in American Samoa, opioid use surveillance, and lung cancer screening disparities. Rosen’s grants include leadership roles in over 10 NIH-funded studies (e.g., microbicide development, HIV/PrEP adherence monitoring). She teaches PHP 2060: Qualitative Methods in Health Research , emphasizing ethical and culturally responsive methodologies. Her work integrates anthropological perspectives with clinical practice, emphasizing participatory approaches to ensure interventions resonate culturally with target populations.

Tony BradshawView profile

Lecturer

• Biochemistry
• Molecular Biology
• Analytical Chemistry
• +2 more

Dr Tony Bradshaw is a Lecturer in Biochemistry at the School of Biological and Medical Sciences , Oxford Brookes University. His work spans analytical chemistry methodologies, molecular biology, and toxicology, with a focus on pharmaceutical analysis, DNA damage mechanisms, and enzyme activity studies. Research Interests Education Publications Research Trends: Dr Bradshaw's publications demonstrate expertise in: Development of chromatographic methods for pharmaceutical analysis Mechanistic studies of DNA damage and repair Investigation of enzyme activity changes during chemical exposure Structural analysis of organic compounds Interferon production modulation

• Pharmaceutical Sciences
• Drug Delivery
• 3D Printing
• +5 more

Mohammed Maniruzzaman is the Chair and Professor of Pharmaceutics and Drug Delivery at the School of Pharmacy , University of Mississippi, with a concurrent appointment as Research Professor in the Research Institute of Pharmaceutical Sciences. His work bridges pharmaceutical process engineering and biomedical innovation. Research focuses on 3D printing and bioprinting of medicines (including biologics and mRNA therapeutics), smart drug delivery implants , hot-melt extrusion for continuous manufacturing, and microbial drug delivery systems . He leads the PharmE3D Lab, which explores ultra-portable delivery devices and co-crystallization processes . Recent publications highlight trends in 3D-printed bone scaffolds , AI-integrated drug delivery , and nano-biocomposite development . His work spans from taste-masking APIs to microneedle patches for transdermal delivery. He has edited special issues in Polymers and AAPS PharmSciTech on additive manufacturing and machine learning in drug delivery.

Navid MadaniView profile

Research Professor

• Virology
• Cancer Immunology
• Microbicide Development
• +2 more

Dr. Navid Madani is a Senior Scientist at Dana-Farber Cancer Institute's Department of Cancer Immunology and Virology with faculty appointments at Harvard Medical School. Her research program develops novel interventions for infectious diseases, focusing on HIV prevention through microbicide development. Madani leads studies optimizing CD4-mimetic small-molecule inhibitors of HIV-1 infection as topical microbicides. She applies scientific approaches to public health projects in cancer and infectious diseases across the MENA region through her leadership of the SHE Center, which addresses health challenges in key populations. Her research bridges virology, immunology, and translational medicine, with emphasis on: Viral entry inhibition mechanisms Antiretroviral drug development Mucosal immunology Translational prevention science

• HIV/AIDS Research
• Biostatistics
• Clinical Trials
• +3 more

Benoît Mâsse is a Full Professor at the School of Public Health, Department of Social and Preventive Medicine, Université de Montréal. His research focuses on HIV/AIDS prevention, biostatistics, and clinical trials, particularly through his role as lead biostatistician for the Microbicide Trials Network (MTN). He specializes in mathematical modeling of infectious disease transmission and statistical analysis of clinical trial data, contributing to global efforts to combat HIV/SIDA. Key affiliations include the Centre de Recherches Mathématiques (CRM) and Centre de recherche Azrieli du CHU Sainte-Justine. He teaches courses such as MSO-6075 (Randomized Clinical Trials) across multiple graduate programs, including Public Health and Pharmaceutical Sciences. His research spans over 20 years, emphasizing microbicide development, vaccine efficacy (e.g., Ebola vaccine trials), and interventions for maternal/child health. He leads or co-leads numerous grants, including studies on pediatric asthma prevention, opioid therapy optimization, and preterm birth prediction. His work integrates biostatistics with clinical and public health challenges. Benoît advises doctoral students on topics like cytomegalovirus infection and clinical trial methodologies. He collaborates extensively with global networks, including NIH-funded initiatives, and contributes to policy-relevant research addressing health inequities and pandemic responses.

Eric WombwellView profile

Clinical Professor

• Healthcare Acquired Infections
• Probiotics
• Antimicrobial Stewardship
• +1 more

Dr. Eric Wombwell is a Clinical Professor in the Division of Pharmacy Practice and Administration at the University of Missouri-Kansas City School of Pharmacy. A board-certified infectious diseases pharmacist, he develops clinical and educational initiatives promoting optimal antimicrobial use. He earned his Pharm.D. at UMKC and completed a residency at Kansas City VA Medical Center. With over 15 years of clinical practice, he maintains affiliations with Centerpoint Medical Center. His research focuses on Healthcare Acquired Infections and Probiotics, particularly Clostridioides difficile prevention strategies. Work includes microbicide nanomedicine for HIV prevention, pulmonary delivery of anticoagulants, and intracerebral drug delivery for epilepsy. Publications emphasize antimicrobial stewardship, infection prevention, and probiotic applications. Recent articles investigate antibiotic susceptibility patterns, probiotic prophylaxis efficacy, and pharmacotherapy education. Research consistently integrates clinical microbiology with therapeutic outcomes. Honors include teaching excellence awards from Rho Chi Society (2022), Phi Lambda Sigma (2021), and multiple UMKC recognitions (2014-2020). He has delivered over 100 continuing education presentations nationally.

• Mucosal Immunology
• Virology
• HIV Transmission
• +5 more

Dr. Deborah J. Anderson is a Professor at Boston University Chobanian & Avedisian School of Medicine with dual appointments in the Department of Obstetrics & Gynecology and the Department of Virology, Immunology & Microbiology. She maintains strong affiliations with Boston University Medical Campus (BMC) and is a leading researcher in reproductive immunology and HIV prevention. Her research program focuses on mucosal immunology at genital tract surfaces, with particular emphasis on understanding immune defense mechanisms against sexually transmitted pathogens. Key research areas include: Development of vaccines and topical microbicides for controlling HIV-1 and other sexually transmitted infections Mechanisms of cell-associated HIV transmission at genital mucosal surfaces Development of monoclonal antibody-based contraceptive technologies Investigation of the vaginal microbiome and its interactions with immune defenses Engineering of bispecific antibodies for non-hormonal contraception Analysis of Dr. Anderson's 15 most recent publications (2021-2025) reveals a clear trajectory toward translational applications of basic immunological discoveries. Her work demonstrates increasing focus on antibody-based multipurpose prevention technologies (MPTs) that combine contraception with HIV prevention. Notable trends include the advancement of the Human Contraceptive Antibody (HCA) through clinical development, innovative formulations of bioadhesive vaginal films for extended antibody release, and pioneering exploration of mRNA-mediated reversible immunocontraception approaches. Her publications span high-impact journals including Science, Journal of Infectious Diseases, and PLoS Medicine, reflecting the significance of her contributions to both basic science and clinical applications. Dr. Anderson has secured substantial research funding as Principal Investigator on multiple NIH grants, including: "Antibody-based Contraceptive MPTs: Advancing the Human Contraceptive Antibody (HCA) through Clinical Trials" (2023-2026, $3.2M) "Development of antisperm antibody-containing penile tubes and bioadhesive films for male contraception" (2023-2025, $750K) "Engineering bispecific antibodies for non-hormonal contraception" (2021-2025, $1.8M) "Synthetic mRNA-Mediated Reversible Immunocontraception" (2021-2024, $1.5M) She serves as a primary mentor for graduate students through Boston University's Graduate Medical Sciences program and leads a multidisciplinary research team comprising immunologists, virologists, and reproductive biologists. Her laboratory maintains active collaborations with Boston Medical Center, Fenway Health, and industry partners including Mucommune LLC and MatTek Corporation to advance promising technologies toward clinical application.

Robin L. JumpView profile

Assistant Professor

• Infectious Diseases
• Antimicrobial Resistance
• Microbiology
• +5 more

Robin L. Jump, MD, PhD, is an Assistant Professor in the Department of Medicine, Division of Infectious Diseases & HIV Medicine at Case Western Reserve University School of Medicine. He is affiliated with the Department of Educational Programs in Clinical Research at the Louis Stokes Cleveland VA Medical Center. His research focuses on preventing Clostridium difficile infections in long-term care facility (LTCF) residents, investigating colonization resistance mechanisms disrupted by antimicrobial use. Education includes a BS in Microbiology & Biochemistry from Colorado State University (1995), followed by a PhD/MD from Case Western Reserve University’s Medical Scientist Training Program (2004). Clinical training includes residencies in Internal Medicine (2007) and Infectious Diseases (2009) at University Hospitals Cleveland Medical Center. Research is supported by grants from the National Institute of Aging (R03 via GEMSSTAR) and the Steris Foundation. His work earned the 2011 Young Investigator Award in Geriatrics. Key areas include nosocomial pathogens such as MRSA, VRE, and multidrug-resistant Gram-negative bacteria, alongside HIV prevention through topical entry inhibitors. He contributes to VA Medical Center educational programs and has published extensively on C. difficile pathogenesis, environmental decontamination, and antibiotic efficacy. His research bridges clinical practice and translational science to improve infection control strategies in vulnerable populations.

Christina FarrView profile

Assistant Professor

• Host-microbe interactions
• Reproductive mucosal immunology
• Sexually transmitted infections
• +4 more

Christina Farr, PhD, is an Assistant Professor in the Department of Pathology at Case Western Reserve University School of Medicine. She holds affiliations with the Center for Global Health and Diseases and the Population and Cancer Prevention Program at the Case Comprehensive Cancer Center. Her research focuses on host-microbe interactions in reproductive health, employing systems immunology approaches combining clinical, model system, and bioinformatics tools. Key areas of interest include mucosal immunology of the female genital tract, sexually transmitted infections, preterm birth mechanisms, and microbiome dynamics. Dr. Farr earned her PhD in Microbiology and Immunology from the University of British Columbia. Her work integrates immunological assays, flow cytometry, and advanced sequencing techniques to study vaginal microbiome composition and its impact on HIV susceptibility and contraceptive effects. She collaborates widely, contributing to studies like the THRIVE observational study examining bacterial vaginosis and the neovaginal microbiome in transgender individuals. Her recent research highlights the role of vaginal microbiome shifts in HIV acquisition risk, the effects of hormonal contraceptives on mucosal immunity, and the development of novel microbicides. Key publications address dapivirine vaginal ring impacts, depot medroxyprogesterone acetate effects, and neutrophil-driven inflammation in dysbiotic microbiomes. Dr. Farr's grants and funding support investigations into microbiome-proteome interactions, HPV prevalence in transfeminine individuals, and the vaginal-vulvar microbiome in lichen sclerosus. Her lab works at the intersection of immunology, microbiology, and global health to advance reproductive tract disease prevention strategies.